Search This Blog

Tuesday, August 13, 2019

Biocept nabs three new patents covering cancer cell detection technology

Biocept (BIOC -5.5%announces the award of three patents, one each in the U.S., Canada and Europe, covering its antibody and microchannel technology and enhanced detection of cancer cells.
Shares are down after its Q2 revenue miss.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.